Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0437
+0.0008 (1.86%)
Mar 26, 2026, 11:53 AM EST
Bioxytran Market Cap
Bioxytran has a market cap or net worth of $5.8 million as of March 26, 2026. Its market cap has decreased by -37.30% in one year.
Market Cap
5.80M
Enterprise Value
7.23M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since September 24, 2018, Bioxytran's market cap has decreased from 25.52M to 5.80M, a decrease of -77.27%. That is a compound annual growth rate of -17.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 5.77M | -29.25% |
| Dec 31, 2025 | 8.15M | 4.49% |
| Dec 31, 2024 | 7.80M | -64.29% |
| Dec 29, 2023 | 21.85M | -63.00% |
| Dec 30, 2022 | 59.05M | 33.18% |
| Dec 31, 2021 | 44.34M | 89.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Brainstorm Cell Therapeutics | 9.82M |
| Synlogic | 8.20M |
| TRON Group | 8.18M |
| NKGen Biotech | 7.84M |
| AccuStem Sciences | 7.71M |
| Nymox Pharmaceutical | 7.19M |
| BetterLife Pharma | 7.11M |
| Mosaic ImmunoEngineering | 5.01M |